APA (7th ed.) Citation

R, M., A, A., U, G., S, B., S, F., N, G., . . . O, B. (2026). Locally manufactured versus commercial CAR T therapy for large B-cell lymphoma: A multicenter propensity scorematched analysis. Haematologica, 111(6), 2023. https://doi.org/10.3324/haematol.2025.288419

Chicago Style (17th ed.) Citation

R, Marcus, et al. "Locally Manufactured Versus Commercial CAR T Therapy for Large B-cell Lymphoma: A Multicenter Propensity Scorematched Analysis." Haematologica 111, no. 6 (2026): 2023. https://doi.org/10.3324/haematol.2025.288419.

MLA (9th ed.) Citation

R, Marcus, et al. "Locally Manufactured Versus Commercial CAR T Therapy for Large B-cell Lymphoma: A Multicenter Propensity Scorematched Analysis." Haematologica, vol. 111, no. 6, 2026, p. 2023, https://doi.org/10.3324/haematol.2025.288419.